603351 Stock Overview
Nanjing Well Pharmaceutical Group Co.,Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 5/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 603351 from our risk checks.
Nanjing Well Pharmaceutical Group Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥24.18 |
| 52 Week High | CN¥27.73 |
| 52 Week Low | CN¥17.65 |
| Beta | 0.41 |
| 11 Month Change | -5.21% |
| 3 Month Change | 14.65% |
| 1 Year Change | -12.14% |
| 33 Year Change | -27.12% |
| 5 Year Change | 8.40% |
| Change since IPO | -7.29% |
Recent News & Updates
Recent updates
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Earnings Are Of Questionable Quality
Aug 26
Nanjing Well Pharmaceutical GroupLtd's (SHSE:603351) Upcoming Dividend Will Be Larger Than Last Year's
Jun 07Little Excitement Around Nanjing Well Pharmaceutical Group Co.,Ltd.'s (SHSE:603351) Earnings
Jun 06Shareholder Returns
| 603351 | CN Chemicals | CN Market | |
|---|---|---|---|
| 7D | -1.7% | -2.5% | -2.0% |
| 1Y | -12.1% | -3.7% | 4.6% |
Return vs Industry: 603351 underperformed the CN Chemicals industry which returned -3.7% over the past year.
Return vs Market: 603351 underperformed the CN Market which returned 4.6% over the past year.
Price Volatility
| 603351 volatility | |
|---|---|
| 603351 Average Weekly Movement | 6.7% |
| Chemicals Industry Average Movement | 8.0% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 603351 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603351's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 673 | Renrong Wu | www.well-js.com |
Nanjing Well Pharmaceutical Group Co.,Ltd. focuses on the research and development, production, and sale of pharmaceutical auxiliary materials in China. Its pharmaceutical materials include excipients for injectables and non-injectables.
Nanjing Well Pharmaceutical Group Co.,Ltd. Fundamentals Summary
| 603351 fundamental statistics | |
|---|---|
| Market cap | CN¥3.28b |
| Earnings (TTM) | CN¥146.83m |
| Revenue (TTM) | CN¥1.33b |
22.3x
P/E Ratio2.5x
P/S RatioIs 603351 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603351 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.33b |
| Cost of Revenue | CN¥981.02m |
| Gross Profit | CN¥346.50m |
| Other Expenses | CN¥199.68m |
| Earnings | CN¥146.83m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.08 |
| Gross Margin | 26.10% |
| Net Profit Margin | 11.06% |
| Debt/Equity Ratio | 25.3% |
How did 603351 perform over the long term?
See historical performance and comparison